Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2013 | 1 |
2018 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood. 2021 Nov 25;138(21):2031-2041. doi: 10.1182/blood.2020009984.
Blood. 2021.
PMID: 34407542
Free PMC article.
Clinical Trial.
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Hochhaus A, Réa D, Boquimpani C, Minami Y, Cortes JE, Hughes TP, Apperley JF, Lomaia E, Voloshin S, Turkina A, Kim DW, Abdo A, Fogliatto LM, le Coutre P, Sasaki K, Kim DDH, Saussele S, Annunziata M, Chaudhri N, Chee L, García-Gutiérrez V, Kapoor S, Allepuz A, Quenet S, Bédoucha V, Mauro MJ.
Hochhaus A, et al. Among authors: bedoucha v.
Leukemia. 2023 Mar;37(3):617-626. doi: 10.1038/s41375-023-01829-9. Epub 2023 Jan 30.
Leukemia. 2023.
PMID: 36717654
Free PMC article.
Clinical Trial.
Item in Clipboard
Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.
Yin OQ, Bédoucha V, McCulloch T, Zheng C, Zhou W, Hussaini A, Novick S.
Yin OQ, et al. Among authors: bedoucha v.
Cancer Chemother Pharmacol. 2013 Jan;71(1):219-26. doi: 10.1007/s00280-012-1999-3. Epub 2012 Oct 16.
Cancer Chemother Pharmacol. 2013.
PMID: 23070146
Clinical Trial.
Item in Clipboard
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.
Ross DM, Masszi T, Gómez Casares MT, Hellmann A, Stentoft J, Conneally E, Garcia-Gutierrez V, Gattermann N, le Coutre PD, Martino B, Saussele S, Giles FJ, Radich JP, Saglio G, Deng W, Krunic N, Bédoucha V, Gopalakrishna P, Hochhaus A.
Ross DM, et al. Among authors: bedoucha v.
J Cancer Res Clin Oncol. 2018 May;144(5):945-954. doi: 10.1007/s00432-018-2604-x. Epub 2018 Feb 22.
J Cancer Res Clin Oncol. 2018.
PMID: 29468438
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite